English Emily — SEC Form 4 filings
SEC reporting owner CIK 2019791. 8 Form 4 filings on record with FilingPulse; latest filed 2026-01-06.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-12-30 to 2026-01-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 1,797 shares, $30,149 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 906 shares @ $16.83 ($15,250) in Cartesian Therapeutics, Inc., filed 2025-01-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | Chief Operations Officer | 8 | — | 2 legs · 1,797 sh · $30,149 | 14 |
Form 4 filings — English Emily
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-06 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Grant/award (A): 24,000 @ $0 · Grant/award (A): 71,000 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Option exercise (M): 7,500 @ $3.30 · Option exercise (M): 7,500 (derivative) | EDGAR |
| 2025-12-02 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Option exercise (M): 7,500 @ $3.30 · Option exercise (M): 7,500 (derivative) | EDGAR |
| 2025-05-14 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Option exercise (M): 7,500 @ $3.30 · Option exercise (M): 7,500 (derivative) | EDGAR |
| 2025-04-16 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Option exercise (M): 7,500 @ $3.30 · Option exercise (M): 7,500 (derivative) | EDGAR |
| 2025-01-07 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Sale (S): 891 @ $16.72 · Sale (S): 906 @ $16.83 | EDGAR |
| 2025-01-06 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Grant/award (A): 16,100 @ $0 · Grant/award (A): 47,400 (derivative) @ $0 | EDGAR |
| 2024-12-30 | 4 | Cartesian Therapeutics, Inc. (RNAC) | Option exercise (M): 7,650 @ $3.30 · Option exercise (M): 7,650 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2019791 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →